26
Views
39
CrossRef citations to date
0
Altmetric
Original Articles

Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years of follow-up

, , , , &
Pages 23-29 | Published online: 18 Jul 2013

References

  • Aguilera, X., Apt, W. & Arribada, A. (1987). Evaluación del alopurinol en la enfermedad de Chagas crónica humana en Chile. Parasitologla al Dia, 11, 132–134.
  • Apt, W. (1999). Tratamiento de la enfermedad de Chagas. Parasitologla al DLI, 23, 100–112.
  • Apt, W., Aguilera, X., Arribada, A., Perez, C., Miranda, C., Sanchez, G., Zulantay, I., Cortés, P., Rodriguez, J. & Juri, D. (1998). Treatment of chronic Chagas disease with itraconazole and allopurinol. American Journal of Tropical Medicine and Hygiene, 59, 133–138.
  • Arribada, A., Apt, W. & Ugarte, J. (1986). A four year follow up survey of chagasic cardiopathy in Chile. Bulletin of the Pan American Health Organization, 20, 254–266.
  • Barret, M., Motram, J. & Coombs, G. (1999). Recent advances in identifying and validating drug targets in trypanosomiasis and leishmaniasis. Trends in Microbiology, 7, 82–88.
  • Croft, S. (1999). Pharmacological approaches to anti-trypanosomal chemotherapy. Menzórias do Instituto Oszvaldo Cruz, 94, 215–220.
  • De Castro, S. L. (1993). The challenge of Chagas disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Tropica, 53, 83–98.
  • Estefani, S., Segura, E. L. & Ruiz, A. M. (1998). Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas disease. American Journal of Tropical Medicine and Hygiene, 59, 526–529.
  • Fragata, A., Luquetti, A., Prata, A., Rassi, A., Gontijo, E., Ferreira, H., Cancado, J., Coura, J., Andrade, S., Vanice, M., Amado Neto, U., Oliveira, W. & Brener, Z. (1997). Etiological treat-ment of Chagas disease. Parasitology Today, 12, 127–130.
  • Gallerano, R., Marr, J. & Soza, R. (1990). Therapeutic efficacy of allopurinol in patients with chronic Chagas disease. American Journal of Tropical Medicine and Hygiene, 43, 159–166.
  • Lazzari, J., Pereira, M., Antunes, C., Guimaraes, A., Moncayo, A., Dominguez, R., Pieretti, O., Macedo, V., Rassi, A., Maguire, J. & Romero, A. (1998). Diagnostic electrocardiography in epidemio-logical studies of Chagas disease: multicenter evaluation of a standardized method. Pan American Journal of Public Health, 4, 317–330.
  • Maguire, J. H., Mott, K. E., Souza, J. A. A., Carvalho, E., Borges, N. & Guimaraes, A. (1982). Clasificación de electrocardiogramas y sistema abreviado de derivaciones para encuestas de poblaciones en relación con la enfermedad de Chagas. Bolean Oficina Sanitaria Panamericana, 93, 102–117.
  • McCabe, E., Remington, J. & Araujo, F. (1986). In vitro and in vivo effect of itraconazole against Thypanosoma cruzi American Journal Tropical Medicine and Hygiene, 35, 280–284.
  • Prata, A. (2000). Clinical and epidemiological aspect of Chagas disease. Lancet Infectious Diseases, 1, 92–100.
  • Viotti, E., Vigliano, C., Armenti, H. & Segura, E. (1994). Treatment of chronic Chagas disease with benznidiazole: clinical and serological evolution of patients with long-term follow-up. American Heart Journal, 127, 151–162.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.